PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology - Crunchbase Company Profile & Funding
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
News Release
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today | The Motley Fool
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Inc
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
